Revenio Group Oyj - Company Announcement

Revenio Group Corporation: 1-2Q /2013 INTERIM REPORT RELEASE DATE CHANGES

Revenio Group Corporation Stock Exchange Release, 26th of April 2013, 15:00 hrs

REVENIO GROUP'S 1-2Q /2013 INTERIM REPORT RELEASE DATE CHANGES

Revenio Group's 1-2q/2013 interim report release date changes. The report will
be released  on 5th of August  2013.

Revenio Group Corporation

Olli-Pekka Salovaara

President and CEO

For further information, please contact:

Olli-Pekka Salovaara, President and CEO, GSM +358 (0) 40 567 5520

olli-pekka.salovaara@revenio.fi

Http://www.revenio.fi



DISTRIBUTION:

NASDAQ OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Key media

www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the operations of Icare Finland Oy. The
widely patented Icare product family is the current cornerstone of the Group's
success. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.

In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.












[HUG#1696909]